Joss Biotec Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 08-07-2024
- Paid Up Capital ₹ 1.48 M
as on 08-07-2024
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.73 M
as on 08-07-2024
- Satisfied Charges ₹ 3.59 M
as on 08-07-2024
- Revenue 28.62%
(FY 2022)
- Profit 16.18%
(FY 2022)
- Ebitda 21.04%
(FY 2022)
- Net Worth 15.60%
(FY 2022)
- Total Assets 8.13%
(FY 2022)
About Joss Biotec
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.48 M.
The company currently has active open charges totaling ₹5.73 M. The company has closed loans amounting to ₹3.59 M, as per Ministry of Corporate Affairs (MCA) records.
Bhaskar Anand and Raj Mahnot serve as directors at the Company.
- CIN/LLPIN
U24232DL2006PTC155792
- Company No.
155792
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Joss Biotec?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhaskar Anand  | Director | 22-Nov-2006 | Current |
| Raj Mahnot | Director | 22-Nov-2006 | Current |
Financial Performance of Joss Biotec.
Joss Biotec Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.62% increase. The company also saw a substantial improvement in profitability, with a 16.18% increase in profit. The company's net worth Soared by an impressive increase of 15.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Joss Biotec?
In 2021, Joss Biotec had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 26 Sep 2023 | ₹4.00 M | Open |
Hdfc Bank Limited Creation Date: 08 Feb 2022 | ₹1.73 M | Open |
State Bank Of India Creation Date: 03 Jun 2020 | ₹0.59 M | Satisfied |
How Many Employees Work at Joss Biotec?
Joss Biotec has a workforce of 16 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Joss Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Joss Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
